other GLP-1RAs (exenatide extended release [ER], dulaglutide and liraglutide) (18, 22, 25)
Adverse Reactions/Side Effects The following serious adverse reactions are described below or elsewhere in the prescribing information: Risk of Thyroid C-cell Tumors [see Warnings and Precautions (5.1)] Acute Pancreatitis [see Warnings and Precautions (5.2)] Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin [see Warnings and Precautions (5.3)] Hypersensitivity Reactions [see Warnings and Precautions (5.4)] Acute Kidney Injury Due to Volume Depletion [see Warnings and Precautions (5.5)] Severe Gastrointestinal Adverse Reactions [see Warnings and Precautions (5.6)] Diabetic Retinopathy Complications in Patients with a History of Diabetic Retinopathy [see Warnings and Precautions (5.7)] Acute Gallbladder Disease [see Warnings and Precautions (5.8)] Pulmonary Aspiration During General Anesthesia or Deep Sedation [see Warnings and Precautions (5.9)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice
The study aims to determine whether methylcobalamin alone, or in combination with either pregabalin or duloxetine, provides better relief from symptoms associated with this condition
The body quickly uses water-soluble vitamins like B and C, excreting any excess through urine
10 We hypothesized that NCTF135 is effective, because during its manufacture all components are stored in the active form through using double extraction purification
Palmery, M., et al., Oral contraceptives and changes in nutritional requirements
